Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss Nanotech Investing
Allarity Therapeutics Closes $20 Million Financing to Accelerate the Advance of Stenoparib Toward FDA Approval and Commercialization Nanotech Investing
Caribou Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update Nanotech Investing
MIMEDX Expands Surgical Product Portfolio with the Launch of AMNIOFIX® Thyroid Shields Nanotech Investing
Nuvation Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update Nanotech Investing
Anixa Biosciences to Host 2026 Annual Meeting of Stockholders and Provide Corporate Update Highlighting Recent Clinical and Regulatory Progress Nanotech Investing
Soleno Therapeutics Announces Retirement of James Mackaness and Appointment of Jennifer Fulk as Chief Financial Officer Nanotech Investing
Soleno Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Update on U.S. Launch of VYKAT XR Nanotech Investing
MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results Nanotech Investing
